-
After hip fracture due to osteoporosis, only 2% of patients had ideal treatment initiated in the hospital with antiresorptive or bone-forming medications combined with calcium and vitamin D
-
The first immunotherapy has been approved by the FDA for the treatment of hormone-resistant prostate cancer.
-
-
Fractures and bisphosphonate therapy, warfarin anticoagulation and influenza vaccine and cotrimoxazole, antiplatelet therapy with clopidogrel and aspirin, FDA Actions.
-
Being overweight or obese increases the risk of cirrhosis. In this study, excess body weight contributed to almost 20% of the cirrhosis-related hospital admissions and deaths, while alcohol contributed to almost 50%.
-
Contrary to the current guidelines, in the long term, an average of approximately 60 min/day of moderate-intensity activity for women is required to be successful in maintaining a normal weight.
-
The FDA has approved a miconazole buccal tablet for the treatment of oropharyngeal candidiasis. This once-daily mucoadhesive buccal tablet provides slow release of the drug over the course of the day. The tablet is marketed by Strativa Pharmaceuticals as Oravig™.
-
A well-established body of epidemiologic literature supports a continuous graded risk between systolic blood pressure (SBP) and CV risk. This relationship has held constant whether one considers office BP, home BP, or ambulatory blood pressure monitoring (ABPM).
-
-
In patients with cardiovascular disease, light-to- moderate alcohol consumption is significantly associated with a lower incidence of cardiovascular and all-cause mortality.
